Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia

Updated on: July 27,2026

Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia

Updated on:July 27,2026

Aspirin may unmask silent bladder cancer by triggering bleeding

byWileyCredit: Unsplash/CC0 Public DomainThe presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood clots, the medication can cause m

Updated on: August 20,2026

Aspirin may unmask silent bladder cancer by triggering bleeding

byWileyCredit: Unsplash/CC0 Public DomainThe presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood clots, the medication can cause m

Updated on:August 20,2026

Serious infection risks linked to targeted cancer therapies

by Carly Murphy,University of California, IrvineCredit: Thirdman from PexelsA major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effec

Updated on: August 20,2026

Serious infection risks linked to targeted cancer therapies

by Carly Murphy,University of California, IrvineCredit: Thirdman from PexelsA major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effec

Updated on:August 20,2026

Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted

Updated on: August 20,2026

Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted

Updated on:August 20,2026

Shrunken genomes may drive rapid cancer evolution and poor outcomes

by Thomas Deane,Trinity College DublinCredit: Pixabay/CC0 Public DomainResearchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and poor pa

Updated on: August 08,2026

Shrunken genomes may drive rapid cancer evolution and poor outcomes

by Thomas Deane,Trinity College DublinCredit: Pixabay/CC0 Public DomainResearchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and poor pa

Updated on:August 08,2026

Experimental drug combination shows early effectiveness in advanced kidney cancer

by Brittany Cordeiro,Mayo ClinicCredit: Unsplash/CC0 Public DomainAn experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a f

Updated on: August 11,2026

Experimental drug combination shows early effectiveness in advanced kidney cancer

by Brittany Cordeiro,Mayo ClinicCredit: Unsplash/CC0 Public DomainAn experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a f

Updated on:August 11,2026

Creatine may supercharge immune cells that are key to fighting cancer

by Tiare Dunlap,University of California, Los AngelesAn artistic rendering of a human dendritic cell. Credit: Don Bliss & Sriram Subramaniam, National Cancer InstituteCreatine, the organic acid th

Updated on: August 19,2026

Creatine may supercharge immune cells that are key to fighting cancer

by Tiare Dunlap,University of California, Los AngelesAn artistic rendering of a human dendritic cell. Credit: Don Bliss & Sriram Subramaniam, National Cancer InstituteCreatine, the organic acid th

Updated on:August 19,2026

Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

by Christopher Lieu,The ConversationKRAS (blue) has been difficult for drugs to target. Credit:Fvasconcellos/Wikimedia CommonsFor a long time, the likelihood of surviving pancreatic cancer has been ex

Updated on: August 19,2026

Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

by Christopher Lieu,The ConversationKRAS (blue) has been difficult for drugs to target. Credit:Fvasconcellos/Wikimedia CommonsFor a long time, the likelihood of surviving pancreatic cancer has been ex

Updated on:August 19,2026

New targeted combination in people with relapsed acute myeloid leukemia shows promise

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainNew research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational tre

Updated on: August 08,2026

New targeted combination in people with relapsed acute myeloid leukemia shows promise

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainNew research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational tre

Updated on:August 08,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on: August 06,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on:August 06,2026

New breakthrough in developing more personalized treatments for lung cancer

byUniversity of BarcelonaSummary of the major findings of this study on the histotype-dependent patterns of SMAD2/3 signaling and their relation with angiogenesis/hypoxia regulation in lung TAFs. Cred

Updated on: August 19,2026

New breakthrough in developing more personalized treatments for lung cancer

byUniversity of BarcelonaSummary of the major findings of this study on the histotype-dependent patterns of SMAD2/3 signaling and their relation with angiogenesis/hypoxia regulation in lung TAFs. Cred

Updated on:August 19,2026

Smartphone app helps those with advanced cancer maintain quality of life

by Dennis ThompsonA smartphone app can help individuals with advanced cancer deal with symptoms and maintain their quality of life, according to new research.TheSUPPORT+ appasks them each week to comp

Updated on: August 15,2026

Smartphone app helps those with advanced cancer maintain quality of life

by Dennis ThompsonA smartphone app can help individuals with advanced cancer deal with symptoms and maintain their quality of life, according to new research.TheSUPPORT+ appasks them each week to comp

Updated on:August 15,2026